SEC Form D · filed February 14, 2018
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Mark M. Sieczkarek · Emeryville, CAExec · DirectorPaul E. Freiman · Newark, NJDirectorMijia (Bob) M. Wu · Emeryville, CADirectorJustin M. Hall · Emeryville, CAExecXinzhou (Paul) E. Li · Emeryville, CADirectorGail J. Maderis · Emeryville, CADirectorJohn J. Mcgovern · Emeryville, CAExecYonghao (Carl) J. Ma · Emeryville, CADirectorTodd J. Zavodnick · Emeryville, CADirectorLewis J. Stuart · Emeryville, CAExecXiaoyan (Henry) J. Liu · Emeryville, CADirectorJohn J. Mcgovern · Emeryville, CAExecMark M. Sieczkarek · Emeryville, CAExec · DirectorPaul E. Freiman · Newark, NJDirectorMijia (Bob) M. Wu · Emeryville, CADirectorJustin M. Hall · Emeryville, CAExecYonghao (Carl) J. Ma · Emeryville, CADirectorXinzhou (Paul) E. Li · Emeryville, CADirectorTodd J. Zavodnick · Emeryville, CADirectorGail J. Maderis · The Woodlands, TXDirectorLewis J. Stuart · Emeryville, CAExecXiaoyan (Henry) J. Liu · Emeryville, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗